Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates
- 29 March 2005
- Vol. 113 (3) , 187-196
- https://doi.org/10.1111/j.1600-0463.2005.apm1130306.x
Abstract
Imipenem resistance in Pseudomonas aeruginosa is considered to be associated with loss of the porin OprD combined with activity of chromosomal beta-lactamase (AmpC), while overexpression of multidrug efflux pumps is considered to confer meropenem resistance. Carbapenem resistance can also result from production of metallo-beta-lactamases. Transcription of oprD and efflux pump genes mexB, mexY and mexF was analysed in 23 clinical isolates of P. aeruginosa by quantitative RT-PCR. oprD was sequenced in all, and mexR, regulator of efflux pump MexAB-OprM, in selected isolates. Four isolates that were imipenem susceptible had significant reduction of oprD mRNA and presence of oprD mutations causing frameshift or translational stop. In strains only resistant to imipenem no significant difference in transcription of oprD was observed between low-level and high-level resistant isolates. The differences could not be explained by either pattern of oprD mutations. Increased transcription of mexB generally correlated well with meropenem resistance. One high-level meropenem-resistant isolate showed no significant change in mexB mRNA, but sequencing confirmed presence of a nalB mutation. Furthermore, one meropenem-susceptible isolate showed significant increase in mexB transcription, but no mexR mutations. In summary, our findings indicate that the resistance patterns observed cannot be fully explained by the currently described carbapenem resistance mechanisms.Keywords
This publication has 30 references indexed in Scilit:
- Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosaClinical Microbiology & Infection, 2004
- Insertional inactivation ofoprD in clinical isolates ofPseudomonas aeruginosaleading to carbapenem resistanceFEMS Microbiology Letters, 2004
- VIM-4 in a Carbapenem-Resistant Strain of Pseudomonas aeruginosa Isolated in SwedenAntimicrobial Agents and Chemotherapy, 2003
- The MexR Repressor of themexAB-oprMMultidrug Efflux Operon inPseudomonas aeruginosa: Characterization of Mutations Compromising ActivityJournal of Bacteriology, 2002
- Extrusion of Penem Antibiotics by Multicomponent Efflux Systems MexAB-OprM, MexCD-OprJ, and MexXY-OprM of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2002
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Rapid identification of mutations in a multidrug efflux pump in Pseudomonas aeruginosaAPMIS, 1999
- Meropenem Permeation through the Outer Membrane of Pseudomonas aeruginosa Can Involve Pathways Other than the OprD Porin ChannelChemotherapy, 1996
- Novel resistance to imipenem associated with an altered PBP-4 in a Pseudomonas aeruginosa clinical isolateJournal of Antimicrobial Chemotherapy, 1990
- Radiolabelling of penicillin-binding proteins (PBPs) in intact Pseudomonas aeruginosa cells: consequences of β-lactamase activity by PBP-5Journal of Antimicrobial Chemotherapy, 1987